Caesarstone opened at $1.28, in line with its previous close of $1.28. In the last trading session, the stock traded between $1.26 and $1.40. It showed an upward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Caesarstone is now worth
$ 10.18
Resulting in a loss of
$ 89.82 (89.82%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
+$0.03 (+2.11%)
Day High
$1.40
Day Low
$1.26
Day Open
$1.28
Prev Close
$1.28
Volume
66,532
1W Return
-19.82%
1M Return
-52.63%
3M Return
-56.14%
6M Return
-4.60%
1Y Return
26.89%
Fundamentals
Market Cap ($ Mn)
45
PE Ratio
-
PB Ratio
1.01
PEG Ratio
-
ROE
-58.75%
ROCE
-37.60%
EPS (TTM)
$-0.45
Investment Returns
1 Week
-19.82%
1 Month
-52.63%
3 Months
-56.14%
6 Months
-4.60%
9 Months
-43.66%
Financials
Quarterly
All values in $ Mn
99.6
Mar 25
101.1
Jun 25
102.1
Sep 25
94.4
Dec 25
88.7
Mar 26
96.6
Jun 26
Updates
11Nov
Caesarstone Q3FY26 Results: Adjusted EBITDA near breakeven, gross margin up 810 bps
Adjusted EBITDA improved to a $0.1 million loss, an $8 million improvement YoY. Gross margin expanded 810 bps to 25.4% due to production shifts and cost cuts. Revenue fell 7.2% YoY in constant currency to $96.3 million amid U.S. demand softness. Net loss widened to $56.1 million driven by a $46.8 million California jury verdict. Cash position remained stable at $50.7 million with no debt to financial institutions.
Yesterday
4Nov
Caesarstone delays Q3 earnings to Nov 11 for legal settlements
Earnings release moved from Nov 4 to Nov 11, 2026. Delay due to legal settlement discussions. Conference call set for 8:30 am ET on Nov 11.
9 days ago
28Oct
Jury awards $67.7 million against Caesarstone in silicosis trial
Jury awards $67.7 million against Caesarstone entities for silicosis. Combined liability assigned to Caesarstone Ltd and Caesarstone USA is 69.1%. Second major verdict in five days brings total damages to over $100 million. Plaintiff Dennys Rene Rivas Williams underwent double-lung transplant at age 37.
15 days ago
22Oct
Caesarstone Q3FY26 Results: Earnings release set for Nov 4 before market open
Caesarstone releases Q3FY26 earnings on November 4, 2026. Conference call scheduled for 8:30 am ET same day. Webcast available via Investor Relations section. Telephonic replay accessible until November 11, 2026.
22 days ago
23Jul
Caesarstone to announce Q2FY26 results on August 5
Caesarstone Ltd. scheduled the release of its second quarter 2026 earnings for August 5, 2026, followed by a conference call at 8:30 a.m. ET. The company provided dial-in numbers for live access and a replay available until August 12, 2026.
